Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First-in-human data for FLT3 inhibitor FF-10101

June 16, 2021

Linnaeus and Merck & Co. expand collaborative evaluation of LNS-8801 with Keytruda

June 16, 2021

Investigator-initiated study of Salarius' seclidemstat in hematologic cancers begins

June 16, 2021

Medshine Discovery discloses ROS1 inhibitors

June 16, 2021

FDA clears IND for lisaftoclax for ER-positive breast cancer and other solid tumors

June 15, 2021

G1 Therapeutics initiates phase II trial of Cosela in metastatic bladder cancer

June 15, 2021

Exelixis and Bristol Myers Squibb agree to study XL-092 with immuno-oncology therapies

June 15, 2021

YL-13027 demonstrates safety and preliminary activity in patients with solid tumors

June 15, 2021

Senda Biosciences identifies new AhR antagonists

June 15, 2021

Suven Life Sciences patents prodrugs of abiraterone for cancer

June 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...